Tools and tactics for studying alternative splicing

Area of Science:

• Molecular Biology
• Genomics
• Bioinformatics

Background:

• Alternative splicing generates crucial transcriptomic diversity for cellular functions.
• Dysregulation of alternative splicing is implicated in various diseases, including cancer and genetic disorders.
• Historically, technical limitations hindered comprehensive analysis of alternative splicing.

Purpose of the Study:

• To highlight recent technological advancements transforming the study of alternative splicing.
• To discuss the implications of these advances for understanding splicing regulation and disease.
• To explore the potential for developing new diagnostic and therapeutic strategies based on splicing profiles.

Main Methods:

• Long-read sequencing for isoform-resolved transcriptomic analysis (bulk, single-cell, spatial).
• CRISPR-based assays for direct functional testing of splicing isoforms.
• Population genetics studies to link genetic variation with splicing and disease risk.
• Deep learning models for deciphering splicing regulatory mechanisms.

Main Results:

• Recent technological breakthroughs overcome previous limitations in mapping and interpreting alternative splicing.
• New methods enable high-resolution analysis of splicing at multiple biological scales.
• Advances facilitate direct functional validation of splicing isoforms and their disease relevance.
• Computational approaches are beginning to decode the complex language of splicing regulation.

Conclusions:

• The convergence of advanced sequencing, gene editing, population studies, and AI is revolutionizing alternative splicing research.
• These developments promise deeper insights into fundamental splicing regulation.
• The findings pave the way for personalized diagnostic and therapeutic strategies targeting individual splicing profiles.